Three federal actions are putting intense pressure on the clinical dietetics workforce, just when it’s needed the most.

The 340B fights of 2026 are being waged as disputes over fairness and intent. Underneath, they are disputes over data.

We’ve built global highways for approved medicines and left clinical trial access on something closer to dirt roads.

Since taking office, the Trump administration has inflicted chaos on Title X, the only federal program that supports the ...

If the relevant question is how to obtain the greatest health value for the money spent, a cost-effectiveness analysis or ...

Exhibit 1 National health expenditures (NHE) and personal health care (PHC) expenditures, aggregate and per capita amounts, share of gross domestic product (GDP), and annual growth, selected calendar ...

The Hikma Court correctly held that a generic manufacturer should not be liable for induced patent infringement if it carves ...

Targeted transparency requirements, clearer guidance on contract pharmacy use, and stronger duplicate-discount safeguards ...

The US spends 25 percent of all health care costs on administration, a big part of which involves billing for medical ...

Regulatory false starts” occur when investments in compliance infrastructure, operational workflow redesign, technology ...

Changing late-life disability and care patterns that may accompany population aging have profound consequences for the nation’s health and related public policies. Drawing on two cross-sectional ...

Congress should strengthen the Medicaid safety net by reforming how the federal government funds state Medicaid programs, ...